Hemolytic anemia after switching from infliximab originator to biosimilar CT-P13 in a patient with inflammatory bowel disease: A case report. [electronic resource]
Publication details: Clinical case reports Nov 2019Description: 2049-2053 p. digitalISSN:- 2050-0904
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.